Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Wall Street sets UNH stock price target

Wall Street sets UNH stock price target
Marko
Stocks

UnitedHealth Group (NYSE: UNH) received a boost on Wednesday, April 1, when Raymond James upgraded the stock from “Market Perform” to “Outperform,” with a $330 price target. 

The financial firm expressed belief that UnitedHealth’s expense upside is now above Wall Street expectations. Analyst John Ransom also mentioned improved general and administrative (G&A) efficiency, saying that even modest gains could have a meaningful impact. Specifically, he predicted every 100-basis-point improvement would add roughly $3.80 per share.

At the same time, visibility into Optum Health, a UnitedHealth branch, has improved, as far as margins are concerned. That is, while margins may look flat this year, the underlying trajectory is positive, as the company exits underperforming operations and streamlines its network.

Operational changes will drive UNH shares

According to Ransom, internal actions are already reinforcing a positive trend. Notably, the company has closed or divested several unprofitable clinics entirely, which has helped relieve margin pressure. ​

Moreover, the management is also working on boosting profitability in its roughly $58 billion risk-based revenue segment, where margins remain below 1%. ​

At the same time, further upside is evident in Optum’s $33 billion non-capitation business, which, although currently generating only single-digit margins, still has plenty of room for improvement with better execution.

UnitedHealth stock price target: Is UNH a buy now?

On Wall Street, UNH currently holds a “Strong Buy” consensus rating, based on seventeen “Buy” recommendations, three “Holds,” and no “Sells” over the past three months, judging by the statistics Finbold retrieved from TipRanks on April 1. 

UNH stock price target. Source: TipRanks

The average UnitedHealth stock price target for the next year sits at $366.47, suggesting a roughly 35.4% upside potential. On the most bullish extreme, analysts see UNH trading at $440, while on the bearish end, they see it at $311 in the same period.

Featured image via Shutterstock

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Finbold Career

Join Finbold's newsroom, become a crypto reporter today!

Apply now to join Finbold as a crypto/finance news writer!

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Finbold AI Agent

How AI Price Predictions Work

We use cutting-edge AI models to forecast future prices for stocks and crypto.

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.